Crossref
journal-article
Elsevier BV
Current Opinion in Immunology (78)
References
66
Referenced
85
10.1073/pnas.93.10.4529
/ Proc Natl Acad Sci USA / Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity and the brain by Darnell (1996)10.1111/j.1750-3639.1993.tb00747.x
/ Brain Pathol / Paraneoplasia and autoimmunologic injury of the nervous system: the anti-Hu syndrome by Rosenblum (1993)10.1212/WNL.42.10.1931
/ Neurology / Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients by Peterson (1992)10.1016/0002-9343(86)90047-1
/ Am J Med / Sensory neuronopathy and small cell lung cancer. Antineuronal antibody that also reacts with the tumor by Graus (1986)10.1002/ana.410180513
/ Ann Neurol / Autoimmune response of patients with paraneoplastic cerebellar degeneration to a Purkinje cell cytoplasmic protein antigen by Jaeckle (1985)10.1016/0092-8674(91)90184-Z
/ Cell / HuD, a paraneoplastic encephalomyelitis antigen contains RNA-binding domains and is homologous to Elav and sex lethal by Szabo (1991)10.1007/PL00000854
/ Cell Mol Life Sci / HuR and mRNA stability by Brennan (2001)10.1073/pnas.96.1.5
/ Proc Natl Acad Sci USA / Why is Hu where? Shuttling of early-response-gene messenger RNA subsets by Keene (1999)10.1523/JNEUROSCI.17-09-03024.1997
/ J NeuroSci / A hierarchy of Hu RNA binding proteins in developing and adult neurons by Okano (1997){'key': '10.1016/j.coi.2004.07.009_bib10', 'first-page': '2136', 'article-title': 'Cdr2, a target antigen of naturally occuring human tumor immunity, is widely expressed in gynecological tumors', 'volume': '60', 'author': 'Darnell', 'year': '2000', 'journal-title': 'Cancer Res'}
/ Cancer Res / Cdr2, a target antigen of naturally occuring human tumor immunity, is widely expressed in gynecological tumors by Darnell (2000)10.1523/JNEUROSCI.17-04-01406.1997
/ J NeuroSci / A post-transcriptional regulatory mechanism restricts expression of the paraneoplastic cerebellar degeneration antigen cdr2 to immune privileged tissues by Corradi (1997)10.1101/gad.13.16.2087
/ Genes Dev / The cytoplasmic Purkinje onconeural antigen cdr2 down-regulates c-Myc function: implications for neuronal and tumor cell survival by Okano (1999)10.1016/0896-6273(93)90077-5
/ Neuron / Nova, the paraneoplastic Ri antigen, is homologous to an RNA-binding protein and is specifically expressed in the developing motor system by Buckanovich (1993)10.1128/MCB.23.13.4687-4700.2003
/ Mol Cell Biol / Nova regulates GABA(A) receptor gamma2 alternative splicing via a distal downstream UCAU-rich intronic splicing enhancer by Dredge (2003)10.1016/S0896-6273(00)80900-9
/ Neuron / Nova-1 regulates neuron-specific alternative splicing and is essential for neuronal viability by Jensen (2000){'key': '10.1016/j.coi.2004.07.009_bib16', 'first-page': '881', 'article-title': 'The expression of the Hu (paraneoplastic encephalomyelitis/sensory neuronopathy) antigen in human normal and tumor tissues', 'volume': '141', 'author': 'Dalmau', 'year': '1992', 'journal-title': 'Am J Pathol'}
/ Am J Pathol / The expression of the Hu (paraneoplastic encephalomyelitis/sensory neuronopathy) antigen in human normal and tumor tissues by Dalmau (1992)10.1016/0140-6736(93)92485-C
/ Lancet / Regression of small-cell lung carcinoma in patients with paraneoplastic neuronal antibodies by Darnell (1993)10.1007/s004150050054
/ J Neurol / Antibodies of the anti-Yo and anti-Ri type in the absence of paraneoplastic neurological syndromes: a long-term survey of ovarian cancer patients by Drlicek (1997)10.1200/JCO.1997.15.8.2866
/ J Clin Oncol / Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival by Graus (1997)10.1002/ana.410270515
/ Ann Neurol / Detection of the anti-Hu antibody in the serum of patients with small cell lung cancer – a quantitative western blot analysis by Dalmau (1990)10.1212/WNL.42.3.536
/ Neurology / Plasmapheresis and antineoplastic treatment in CNS paraneoplastic syndromes with antineuronal autoantibodies by Graus (1992)10.1212/WNL.40.7.1085
/ Neurology / Autoantibody synthesis in the central nervous system of patients with paraneoplastic syndromes by Furneaux (1990)10.1212/WNL.45.10.1873
/ Neurology / Immunization with the paraneoplastic encephalomyelitis antigen HuD does not cause neurologic disease in mice by Sillevis Smitt (1995)10.1016/0165-5728(95)00063-8
/ J Neuroimmunol / Induction of anti-Purkinje cell antibodies in vivo by immunizing with a recombinant 52-kDa paraneoplastic cerebellar degeneration-associated protein by Sakai (1995)10.1006/jaut.2001.0553
/ J Autoimmun / Induction of cytotoxic T lymphocytes specific for paraneoplastic cerebellar degeneration-associated antigen in vivo by DNA immunization by Sakai (2001)10.1212/WNL.44.1.140
/ Neurology / Analysis of the IgG subclass distribution and inflammatory infiltrates in patients with anti-Hu-associated paraneoplastic encephalomyelitis by Jean (1994)10.1007/s004010050460
/ Acta NeuroPathol / Inflammatory infiltrates and complete absence of Purkinje cells in anti-Yo-associated paraneoplastic cerebellar degeneration by Verschuuren (1996)10.1038/3315
/ Nat Med / Tumor-specific killer cells in paraneoplastic cerebellar degeneration by Albert (1998)10.1002/1531-8249(200001)47:1<9::AID-ANA5>3.0.CO;2-I
/ Ann Neurol / Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration by Albert (2000)10.1016/S0022-510X(01)00548-2
/ J Neurol Sci / Cytotoxic T cell activity against the peptide, AYRARALEL, from Yo protein of patients with the HLA A24 or B27 supertype and paraneoplastic cerebellar degeneration by Tanaka (2001)10.1212/WNL.51.4.1146
/ Neurology / T-cell receptor analysis in anti-Hu associated paraneoplastic encephalomyelitis by Voltz (1998)10.1016/S0022-510X(01)00442-7
/ J Neurol Sci / Antibody types and IgG subclasses in paraneoplastic neurological syndromes by Greenlee (2001)10.1016/S0165-5728(00)00445-8
/ J Neuroimmunol / Restricted IgG1 subclass of anti-Yo antibodies in paraneoplastic cerebellar degeneration by Amyes (2001)10.1002/1531-8249(199902)45:2<162::AID-ANA5>3.0.CO;2-R
/ Ann Neurol / Cell-mediated autoimmunity in paraneoplastic neurological syndromes with anti-Hu antibodies by Benyahia (1999)10.1146/annurev.immunol.19.1.47
/ Annu Rev Immunol / Cross-presentation, dendritic cells, tolerance and immunity by Heath (2001)10.1084/jem.188.7.1359
/ J Exp Med / Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes by Albert (1998)10.1038/32183
/ Nature / Dendritic cells acquire antigen from apoptotic cells and induce class I- restricted CTLs by Albert (1998)10.1038/ni722
/ Nat Immunol / Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells by Albert (2001)10.1038/30996
/ Nature / Help for cytotoxic-T-cell responses is mediated by CD40 signalling by Bennett (1998)10.1038/31002
/ Nature / T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions by Schoenberger (1998)10.1038/30989
/ Nature / A conditioned dendritic cell can be a temporal bridge between a CD4+ T- helper and a T-killer cell by Ridge (1998)10.1126/science.1891717
/ Science / Viral persistence in neurons explained by lack of major histocompatibility class I expression by Joly (1991)10.1016/S0896-6273(00)80562-0
/ Neuron / Regulation of class I MHC gene expression in the developing and mature CNS by neural activity by Corriveau (1998)10.1126/science.290.5499.2155
/ Science / Functional requirement for class I MHC in CNS development and plasticity by Huh (2000)10.1084/jem.185.2.305
/ J Exp Med / Major histocompatibility complex (MHC) class I gene expression in single neurons of the central nervous system: differential regulation by interferon (IFN)-gamma and tumor necrosis factor (TNF)-alpha by Neumann (1997)10.1002/(SICI)1098-1136(20000215)29:4<293::AID-GLIA1>3.0.CO;2-A
/ Glia / Brain-immune connection: immuno-regulatory properties of CNS-resident cells by Becher (2000)10.1126/science.2580350
/ Science / Selective extraction of small and large molecules from the cerebrospinal fluid by Purkinje neurons by Borges (1985)10.1056/NEJMra023009
/ N Engl J Med / Paraneoplastic syndromes involving the nervous system by Darnell (2003)10.1212/WNL.43.10.2049
/ Neurology / Type IIa (‘anti-Hu’) antineuronal antibodies produce destruction of rat cerebellar granule neurons in vitro by Greenlee (1993)10.1016/0022-510X(91)90198-G
/ J Neurol Sci / Effect of intraventricular injection of an anti-Purkinje cell antibody (anti-Yo) in a guinea pig model by Graus (1991)10.1084/jem.178.6.2219
/ J Exp Med / The synaptic vesicle-associated protein amphiphysin is the 128-kD autoantigen of Stiff-Man syndrome with breast cancer by De Camilli (1993)10.1016/0092-8674(95)90474-3
/ Cell / β-NAP, a cerebellar degeneration antigen, is a neuron-specific vesicle coat protein by Newman (1995)10.1083/jcb.118.2.309
/ J Cell Biol / Membrane anchoring of the autoantigen GAD 65 to microvesicles in pancreatic beta-cells by palmitoylation in the NH2-terminal domain by Christgau (1992)10.1016/S0896-6273(00)81165-4
/ Neuron / Autoimmunity to gephyrin in Stiff-Man syndrome by Butler (2000)10.1002/ana.410330407
/ Ann Neurol / Analysis of autoantibody binding to 52-kd paraneoplastic cerebellar degeneration-associated antigen expressed in recombinant proteins by Sakai (1993)10.1002/ana.410380117
/ Ann Neurol / Hu antigens: reactivity with Hu antibodies, tumor expression, and major immunogenic sites by Manley (1995)10.1523/JNEUROSCI.16-03-01114.1996
/ J NeuroSci / The onconeural antigen Nova-1 is a neuron-specific RNA-binding protein, the activity of which is inhibited by paraneoplastic antibodies by Buckanovich (1996)10.1084/jem.193.8.967
/ J Exp Med / The clinical course of experimental autoimmune encephalomyelitis and inflammation is controlled by the expression of CD40 within the central nervous system by Becher (2001)10.1084/jem.20031064
/ J Exp Med / The activation status of neuroantigen-specific T cells in the target organ determines the clinical outcome of autoimmune encephalomyelitis by Kawakami (2004)10.1084/jem.192.6.871
/ J Exp Med / In situ tolerance within the central nervous system as a mechanism for preventing autoimmunity by Brabb (2000)10.1111/j.1750-3639.1991.tb00646.x
/ Brain Pathol / Migration of hematogenous cells through the blood-brain barrier and the initiation of CNS inflammation by Hickey (1991)10.1006/smim.1999.0168
/ Semin Immunol / Leukocyte traffic in the central nervous system: the participants and their roles by Hickey (1999)10.1038/nri1130
/ Nat Rev Immunol / Three or more routes for leukocyte migration into the central nervous system by Ransohoff (2003){'year': '1995', 'series-title': 'Neurologic Complications of Cancer', 'author': 'Posner', 'key': '10.1016/j.coi.2004.07.009_bib64'}
/ Neurologic Complications of Cancer by Posner (1995)10.1002/ana.20049
/ Ann Neurol / Expression of CCR7 in Multiple Sclerosis: Implications for CNS Immunity by Kivisakk (2004)10.1038/ni1073
/ Nat Immunol / CD8+ T cells maintain tolerance to myelin basic protein by ‘epitope theft’ by Perchellet (2004)
Dates
Type | When |
---|---|
Created | 21 years ago (Aug. 21, 2004, 5:11 a.m.) |
Deposited | 6 years, 6 months ago (Feb. 4, 2019, 10:28 a.m.) |
Indexed | 11 hours, 52 minutes ago (Aug. 28, 2025, 8:53 a.m.) |
Issued | 20 years, 10 months ago (Oct. 1, 2004) |
Published | 20 years, 10 months ago (Oct. 1, 2004) |
Published Print | 20 years, 10 months ago (Oct. 1, 2004) |
@article{Roberts_2004, title={Neuroimmunology of the paraneoplastic neurological degenerations}, volume={16}, ISSN={0952-7915}, url={http://dx.doi.org/10.1016/j.coi.2004.07.009}, DOI={10.1016/j.coi.2004.07.009}, number={5}, journal={Current Opinion in Immunology}, publisher={Elsevier BV}, author={Roberts, Wendy K and Darnell, Robert B}, year={2004}, month=oct, pages={616–622} }